The Heart Question Hanging Over Xylitol

Originally published 13 September 2026 · Updated 17 September 2026 with expanded population evidence and published expert criticism.

Xylitol sits in chewing gum, sugar-free sweets, some baked goods and dental products, and is sold as a lower-calorie, lower-glycaemic alternative to sugar. That has made it especially attractive in products aimed at people cutting sugar, managing weight or watching blood glucose. New research raises an awkward question about exactly those people: could high exposure carry cardiovascular effects of its own?

TL;DR

• Xylitol is a sugar alcohol. It is used as a low-calorie sweetener and widely positioned as a healthier alternative to sugar.
• A 2024 Cleveland Clinic study found a clear association. People in the highest third of blood xylitol had a 57% higher adjusted three-year risk of major cardiovascular events than those in the lowest third.
• That study went beyond association. Xylitol enhanced platelet reactivity and thrombus formation in laboratory and animal work, and raised platelet responsiveness in every one of ten volunteers who drank it.
• Larger research followed in 2026. Findings presented at the ESC Congress covered 17,710 people in two general-population cohorts, with 57% higher risk in one and 18% in the other.
• Those 2026 figures are provisional. They were presented at a conference and have not completed peer review.
• Other researchers have pushed back. The published criticism focuses on the size and design of the human intervention, and on whether blood xylitol is a cause or a bystander.
• Blood levels are not dietary intake. No dietary dose at which risk begins has been established.

What Xylitol Is

Xylitol is a sugar alcohol, a class that also includes erythritol, sorbitol and maltitol. It occurs naturally in small quantities in fruit and vegetables, and the body produces small amounts itself. That last point cuts both ways. Endogenous production runs at levels more than a thousand times lower than those seen after eating xylitol as a sugar substitute, so "your body makes it anyway" says little about dietary exposure. But it also means a high fasting blood level is not automatically a measure of who chews the most sugar-free gum, which matters for how the research below should be read.

Sometimes sold as birch sugar, it is roughly as sweet as sucrose with around 40% fewer calories, does not raise blood glucose significantly, and has real dental benefits, which is why it appears in toothpaste and gum.

The 2024 Study: An Association, Then a Mechanism

The work that started this came from a team led by Dr Stanley Hazen at the Cleveland Clinic, published in the European Heart Journal in 2024. The group had previously reported similar findings for erythritol.

They began with untargeted metabolomics on fasting plasma from a discovery cohort of 1,157 patients undergoing elective cardiac evaluation, which flagged a compound tentatively identified as xylitol. That is why the next step mattered: in an independent validation cohort of 2,149 patients, a method specific to xylitol rather than its structural isomers confirmed the association. People in the highest tertile of blood xylitol had a 57% higher adjusted risk of a major adverse cardiovascular event over three years than those in the lowest tertile, a hazard ratio of 1.57 with a 95% confidence interval of 1.12 to 2.21. The adjustment included age, sex, smoking, diabetes, systolic blood pressure and cholesterol. The difference between the lowest and middle tertiles was not significant.

An association in cardiac patients is interesting but limited, and what followed is what makes the study unusual. In laboratory work using isolated platelets, platelet-rich plasma and whole blood, and in an animal model of arterial injury, xylitol enhanced multiple measures of platelet reactivity and thrombus formation at the concentrations seen in fasting plasma. Greater platelet reactivity increases clotting potential, which is directly relevant to heart attack and ischaemic stroke.

The team then ran a small human study. Ten healthy volunteers drank 30g of xylitol dissolved in water, an amount the authors describe as comparable to a typical portion of a xylitol-sweetened food. Plasma xylitol rose sharply, every measure of platelet responsiveness increased in every participant, and levels returned to low-micromolar values within four to six hours. That structure, an association plus a proposed mechanism plus a demonstration that consuming the substance acutely changes that mechanism in people, is stronger than most nutrition epidemiology offers.

The 2026 Research: Beyond Cardiac Patients

The obvious limitation of the 2024 work was the population, since everyone in it was already undergoing cardiac evaluation. Research presented at the European Society of Cardiology Congress in Munich in August 2026, led by Dr Marco Witkowski of Charité University Hospital in Berlin, addressed that. The team measured circulating xylitol in 17,710 people across two general-population cohorts: the Canadian Longitudinal Study on Aging, with six years of follow-up, and EPIC-Norfolk, with thirty.

The direction held. Comparing the highest quartile of blood xylitol with the lowest, the risk of major adverse cardiovascular events, defined as death, heart attack or stroke, was 57% higher in the Canadian cohort and 18% higher in EPIC-Norfolk. Data from the middle quartiles pointed to a dose-dependent relationship, with event rates rising as xylitol levels rose. The researchers reported that the pattern held irrespective of characteristics such as age and sex, and independently of body mass index, hypertension, diabetes and lipid levels, which is relevant because those factors also predict who buys low-calorie products in the first place.

The gap between the two cohorts is worth noting rather than averaging away. It may reflect differences in population, follow-up length or how each cohort was assembled, so any single headline percentage oversimplifies. Until the full paper appears, the methods and models cannot be scrutinised as closely as the 2024 study.

What Other Researchers Have Said

This is a contested area, and the argument has played out in the same journal that published the original paper.

An accompanying European Heart Journal editorial treated the findings as a serious warning signal, noting that the three-year associations with cardiovascular events and stroke were statistically significant and clinically relevant, and arguing that sugar alcohol sweeteners now warrant a closer look from regulators.

Others were more sceptical. One group argued that the ten-person intervention was too small to carry the weight placed on it, had no placebo arm, and measured platelet responses at a single timepoint 30 minutes after ingestion, when aggregation also shifts in response to ordinary things like exercise and eating. On their reading, the defensible claims are narrower: that endogenous xylitol production is raised in people at cardiovascular risk, and that intake may have a short-term effect on platelet aggregation. A second letter asked whether elevated serum xylitol is an active contributor or an innocent bystander, since observational data can only show association. Researchers in oral health objected differently, pointing to decades of evidence on the safety of xylitol in dental use.

Hazen and Witkowski replied to each. Their central point is that the acute safety of xylitol in oral care has been studied while the long-term cardiovascular effects of dietary xylitol have not, which is why they moved beyond observation into mechanistic and interventional work. They also note a separate intervention in which 30g of erythritol, but not the same amount of glucose, increased platelet responsiveness.

The Caveats, Stated Plainly

The 2026 findings are conference evidence, presented at the ESC Congress rather than published after peer review, so the figures could still change. Given the sample size that is not grounds for dismissal, but it is grounds for treating them as provisional.

Blood levels are not dietary intake, and this is the limitation most coverage skips. The observational studies measured fasting circulating xylitol. Because the body makes xylitol itself, high fasting levels may partly reflect individual metabolism rather than how much sugar-free gum or confectionery someone gets through. The human intervention shows that dietary xylitol can raise plasma levels sharply; it does not establish that diet explains why some people had chronically higher fasting concentrations.

Ten volunteers can show an acute effect, not a chronic outcome: the intervention demonstrated that drinking xylitol changes platelet measures within half an hour, not that regularly eating it causes heart attacks or strokes years later. Nor has any dose threshold been established. Nothing in this research identifies a level of dietary intake at which risk begins, and no prospective trial has tested how habitual consumption translates into events.

Who This Is About

Sugar alcohols occupy an awkward position in dietary advice. Current guidance is more measured than the marketing suggests: the American Diabetes Association recommends water over both sweetened and non-nutritively sweetened drinks, while allowing non-nutritive sweeteners as a moderate, short-term substitute where that cuts calories and carbohydrate, and notes there is little research on benefits specific to sugar alcohols. So it would be wrong to say modern diabetes guidance recommends xylitol. What is true is that xylitol is marketed heavily to people managing blood glucose and weight, and those people are, on average, already at raised cardiovascular risk. That is the heart of Hazen's argument about the 2024 findings: if xylitol does increase clotting potential, the people most exposed to it are the ones least able to absorb that risk. If further research bears this out, the problem is as much about product positioning as about the compound.

What This Doesn't Mean

Toothpaste is not the concern raised by these studies, because it is a topical exposure and is not meant to be swallowed. Foods, sweets, drinks and heavily used gum are different: xylitol in gum is released, swallowed in saliva and absorbed, and heavy use delivers meaningful quantities.

It is not an argument for going back to sugar, because the case against high sugar intake has not weakened; what this research complicates is the assumption that sugar alcohols are a safe swap. Nor is it a verdict on the whole class, since the similar findings for erythritol raise a broader question without showing that every polyol behaves the same way. And it is not settled: both research teams call for further cardiovascular safety studies, which is the right conclusion from where the evidence sits.

What This Actually Means

The evidence has moved beyond a statistical association without reaching proof of harm. That is an uncomfortable middle position, but it is where things are.

If xylitol makes up a substantial part of your sugar substitution, this is worth knowing about, particularly if you already have cardiovascular or metabolic risk factors. There is not enough evidence to set an intake limit, and not enough to assume high habitual intake is neutral either. Checking labels is reasonable if it matters to you, because xylitol appears in sugar-free confectionery, some peanut butters, protein and keto products, baked goods and drinks, often without prominence. What is still missing is the part readers most want: whether eating xylitol causes cardiovascular events, how much would matter, and whether cutting back reduces risk.

Frequently Asked Questions

Is xylitol bad for your heart?

Research links high circulating xylitol with a greater risk of major cardiovascular events, and mechanistic work suggests it increases platelet reactivity. That is stronger than most dietary associations, but it does not establish that eating xylitol causes those events.

How much does xylitol increase cardiovascular risk?

Estimates vary. The 2024 study in cardiac patients found a 57% higher adjusted three-year risk in the highest versus lowest tertile of blood levels. The 2026 research across two general-population cohorts found 57% higher risk in one and 18% in the other, comparing highest and lowest quartiles.

How does xylitol affect the blood?

Laboratory and animal work found that xylitol enhanced platelet reactivity and clot formation. In a ten-person study, drinking 30g of xylitol raised plasma levels and increased platelet responsiveness in every participant, with levels falling back within four to six hours.

Should I stop using xylitol toothpaste?

These studies do not raise that concern. Toothpaste is primarily a topical exposure and is not intended to be swallowed. Products that are eaten or drunk are different.

Is there a safe amount of xylitol?

No dietary threshold has been established. The research measured circulating blood levels rather than habitual intake, and no prospective trial has shown how different levels of consumption translate into cardiovascular events.

Are these findings peer-reviewed?

The 2024 Cleveland Clinic study was published in the European Heart Journal, along with an editorial and several critical letters and replies. The 2026 general-population research was presented at the ESC Congress and had not completed peer review at the time of writing.

The Bottom Line

Most nutrition scares rest on an association and a plausible story. This one has more behind it: observational findings in cardiac patients, replication across two much larger population cohorts, platelet and animal experiments, and a small human study showing that drinking xylitol acutely changes platelet responsiveness. It still is not proof, and serious researchers have said so in print. The 2026 findings await peer review, fasting blood levels may partly reflect individual metabolism rather than diet, and nobody has established how much dietary xylitol, over how long, would matter.

What makes it worth attention is the positioning. Xylitol is sold as a healthier substitute for sugar, including in products aimed at people watching their weight or blood glucose. There is now enough evidence to question the assumption that high exposure is cardiovascularly neutral, and not enough to conclude that eating xylitol causes heart attacks or strokes. The next question is not whether xylitol can affect platelets, because it can. It is whether the amounts people consume change outcomes over time, and that study still needs doing.

This is general information rather than medical advice. If you are managing diabetes or cardiovascular risk and use sugar-free products regularly, speak to your GP or a registered dietitian before making changes.